SHAREHOLDERS' EQUITY - Narrative (Details)			3 Months Ended		64 Months Ended
	Jul. 18, 2021	Feb. 04, 2020 USD ($) sales_agent	Jun. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2024 USD ($) $ / shares shares	May 21, 2024 USD ($)	May 20, 2024 USD ($)	Aug. 02, 2022 USD ($)	Aug. 01, 2022 USD ($)	Aug. 31, 2021 USD ($)	Jul. 28, 2021 USD ($)	May 26, 2021 USD ($)	Mar. 04, 2019 USD ($)
Subsidiary or Equity Method Investee [Line Items]
Repurchase authorized amount										$ 20,000,000	$ 20,000,000
Restricted Stock | 2010 Plan
Subsidiary or Equity Method Investee [Line Items]
Right to grant period	10 years
Equity ATM Program
Subsidiary or Equity Method Investee [Line Items]
Maximum consideration threshold		$ 100,000,000.0				$ 1,000,000,000	$ 650,000,000	$ 650,000,000.0	$ 250,000,000.0			$ 250,000,000.0	$ 50,000,000.0
Number of additional sales agents | sales_agent		2
Gross sales commission percentage												1.50%	2.00%
Number of shares sold (in shares) | shares			1,498,981	2,527,458	26,845,418
Weighted average price per share (in usd per share) | $ / shares			$ 25.60	$ 18.03	$ 21.13
Gross proceeds received			$ 38,367,000	$ 45,572,000	$ 567,300,000
Net proceeds received			37,792,000	$ 44,888,000	558,300,000
Available under the Equity ATM Program			$ 432,700,000		$ 432,700,000